The report provides a snapshot of the global therapeutic landscape for TGF Beta Receptor Type 1

The report reviews TGF Beta Receptor Type 1 targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

We want to thank the many editors, contributors, and reviewers that helped make this journal a leading publication in its field. We also want to thank you, the readers, for giving our efforts purpose and meaning. It has been a privilege serving you through our printed edition and online.